Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Delorme
Friedhelm Raue

Showing results (31-40 of 232) with videos related to

Pageof 24
Sort By:
Plos One|March 1, 2019
CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 casesNassim Fard, Heinz-Peter Schlemmer, Friedhelm Raue, et al.
Clinical Laboratory|July 4, 2007
Change in the spectrum of RET mutations diagnosed between 1994 and 2006Karin Frank-Raue, Susanne Rondot, Egbert Schulze, et al.
Surgery|November 4, 2004
Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutationAndreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2017
Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New MillenniumFriedhelm Raue, Henning Dralle, Andreas Machens, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 19, 2020
Lung Cancer Screening by Low-Dose Computed Tomography: Part 2 - Key Elements for Programmatic Implementation of Lung Cancer ScreeningStefan Delorme, Rudolf Kaaks
Radiologie (Heidelberg, Germany)|August 4, 2022
[Crossing borders]Fabian Kiessling, Stefan Delorme
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 4, 2006
Contrast-enhanced ultrasound for examining tumor biologyStefan Delorme, Martin Krix
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 19, 2020
Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population TargetingRudolf Kaaks, Stefan Delorme
Radiologie (Heidelberg, Germany)|May 28, 2024
[Do no harm!]Stefan Delorme, Rudolf Kaaks
The Lancet. Oncology|August 14, 2022
What is the best choice of follow-up procedure following resection of lung cancer?Ursula Nestle, Stefan Delorme
Pageof 24

Showing results (31-40 of 232) with videos related to

Sort By:
Pageof 24
Plos One|March 1, 2019
CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 casesNassim Fard, Heinz-Peter Schlemmer, Friedhelm Raue, et al.
Clinical Laboratory|July 4, 2007
Change in the spectrum of RET mutations diagnosed between 1994 and 2006Karin Frank-Raue, Susanne Rondot, Egbert Schulze, et al.
Surgery|November 4, 2004
Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutationAndreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2017
Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New MillenniumFriedhelm Raue, Henning Dralle, Andreas Machens, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 19, 2020
Lung Cancer Screening by Low-Dose Computed Tomography: Part 2 - Key Elements for Programmatic Implementation of Lung Cancer ScreeningStefan Delorme, Rudolf Kaaks
Radiologie (Heidelberg, Germany)|August 4, 2022
[Crossing borders]Fabian Kiessling, Stefan Delorme
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 4, 2006
Contrast-enhanced ultrasound for examining tumor biologyStefan Delorme, Martin Krix
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 19, 2020
Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population TargetingRudolf Kaaks, Stefan Delorme
Radiologie (Heidelberg, Germany)|May 28, 2024
[Do no harm!]Stefan Delorme, Rudolf Kaaks
The Lancet. Oncology|August 14, 2022
What is the best choice of follow-up procedure following resection of lung cancer?Ursula Nestle, Stefan Delorme
Pageof 24